by in
Entry Author Date Location
Eli Lilly CEO John Lechleiter on Tackling the Pharmaceutical R&D Crisis (Part 2) 11/22/11 National
Merck Unveils Alzheimer’s and Diabetes Projects, Personnel Changes 11/10/11 New York
Raising Funds: AnaptysBio, Sonexa, Eclipse, NextDx, Naviscan 10/18/11 San Diego
Integrated Diagnostics, Leroy Hood’s Latest Startup, Pockets $10M After Hitting Early Goals 07/22/10 Seattle
Consumer Genetics Needs More Transparency, Not Excessive Regulation 06/23/10 National
Quanterix Uses Fiber Optics to Find Cancer Protein, Nears New Funding Round 05/27/10 Boston
New England’s Lucky Seven: Under the Radar Startup Financings in April 05/25/10 Boston
Avalon Raising New Fund, Althea Technologies Gets Altus Assets, Trancon Pharmaceuticals Nabs Financing, & More San Diego Life Sciences News 05/06/10 San Diego
Lee Hood’s Startup for Personalized Medicine, Integrated Diagnostics, Hires First CEO 03/29/10 Seattle
San Diego’s Acadia Pharmaceuticals Updates Plans for Experimental Parkinson’s Drug 03/10/10 San Diego
Genomic Advances of the 2000s Will Demand an Informatics Revolution in the 2010s 01/14/10 National
Novartis Parts Ways with Idera Pharma 11/25/09 Boston
Sirtris Advancing No. 1 Drug into Mid-Stage Clinical Trials for Type 2 Diabetes 10/14/09 Boston
Epix Pharma Shuts Down 07/21/09 Boston
Zenobia Therapeutics, Inspired by Warrior Queen, Focuses on Developing Drug for Parkinson’s Disease 04/22/09 San Diego
Epix Pharma Halves Workforce 03/12/09 Boston
TheraGenetics Bought by Avacta 01/29/09 Boston
Idera and Merck Extend R&D Deal 11/20/08 Boston
Novartis Option Fund Managing Director Says First Responsibility is to Portfolio Companies, Dislikes “Corporate VC” Moniker 10/31/08 Boston
Epix Cutting 23 Percent of Workers 10/23/08 Boston
Page 2 of 2 « previous page